glp 1 agonist heart disease GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Cardiovascular and mortality outcomes with
Description
Endocrinol Metab (Seoul) 40: 112124, 2025
A version of this story first appeared in ACS Central Science : cenm.ag/glp-1-mentalhealth.
The director seems to forget that state taxpayers also fund the federal government
Jr., et al
